J and J Shares Poised to Hit Record After Earnings

The company\'s stock rose about 1.4 percent $112.50 in premarket trading, on track to open at a record high.

Published: 19th April 2016 05:27 PM  |   Last Updated: 19th April 2016 05:51 PM   |  A+A-


A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016 | Reuters

Johnson & Johnson, the maker of Band-Aids and Tylenol, reported higher-than-expected quarterly earnings on Tuesday and nudged up its 2016 sales and earnings forecasts.

The company's stock rose about 1.4 percent $112.50 in premarket trading, on track to open at a record high.

J&J's first-quarter sales rose 0.6 percent to $17.48 billion, led by demand for pharmaceutical products in the United States. Overall, though, sales were constrained by the strong dollar and Venezuela's currency devaluation.

Net earnings fell to $4.29 billion, or $1.54 per share, from $4.32 billion, or $1.53 per share, a year earlier.

Excluding special items, the company earned $1.68 per share, compared with the average analysts' estimate of $1.65, according to Thomson Reuters I/B/E/S.

J&J said that based on current exchange rates, it now expected sales of $71.2 billion to $71.9 billion in 2016, up from its January forecast of $70.8 billion to $71.5 billion.

On an adjusted basis, it said it expected to earn $6.53-$6.68 per share for the year, up from its prior estimate of $6.43-$6.58.

The company's pharmaceutical unit accounted for 45 percent of its $70 billion in sales last year. Medical devices made up for more than a third of sales, with over-the-counter medicines and other consumer products making up the rest.

Stay up to date on all the latest Business news with The New Indian Express App. Download now


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp